Biden White House Paying $10.6 Billion for Pfizer’s COVID-19 Paxlovid
By Guest PosT— June 27, 2022 OPINION Biden White House Paying $10.6 Billion for Pfizer’s COVID-19 Paxlovid Flop by David Gortler Back in November 2021, the White House paid drugmaker Pfizer nearly $5.3 billion ($5,290,000,000) for 10 million treatment courses of its experimental COVID-19 treatment. Paxlovid is an antiviral combination of nirmatrelvir and ritonavir. Ritonavir was […]Read More